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GABA transporters belong to a large family of neurotransmitter:sodium symporters. They
are widely expressed throughout the brain, with different levels of expression in different
brain regions. GABA transporters are present in neurons and in astrocytes and their activity
is crucial to regulate the extracellular concentration of GABA under basal conditions and
during ongoing synaptic events. Numerous efforts have been devoted to determine the
structural and functional properties of GABA transporters. There is also evidence that the
expression of GABA transporters on the cell membrane and their lateral mobility can be
modulated by different intracellular signaling cascades. The strength of individual synaptic
contacts and the activity of entire neuronal networks may be finely tuned by altering the
density, distribution and diffusion rate of GABA transporters within the cell membrane.
These findings are intriguing because they suggest the existence of complex regulatory
systems that control the plasticity of GABAergic transmission in the brain. Here we review
the current knowledge on the structural and functional properties of GABA transporters
and highlight the molecular mechanisms that alter the expression and mobility of GABA
transporters at central synapses.
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INTRODUCTION
The brain utilizes GABAergic synaptic transmission to modu-
late the ongoing activity of neuronal networks. By acting on
ionotropic and metabotropic receptors, GABA controls the gen-
eration of membrane potential oscillations, the time window over
which synaptic inputs are integrated and the temporal structure
of the activity patterns produced by entire populations of neu-
rons (Pouille and Scanziani, 2001; Hajos et al., 2004; Akam and
Kullmann, 2010; Mann andMody, 2010; Stark et al., 2013). These
actions require a fine control of the timing of GABA receptor acti-
vation which, in turn, depends on the precise timing of GABA
release from pre-synaptic terminals and GABA clearance from the
extracellular space. Extracellular GABA is not subject to enzy-
matic breakdown, and its clearance relies entirely on diffusion
and uptake by specific transporters. GABA transporters belong
to a large family of neurotransmitter:sodium symporters, and are
widely expressed throughout the brain. GABA transporters are
expressed in different cell types, including neurons and astro-
cytes, at expression levels that vary across different brain regions.
Experimental evidence indicates that the distribution of GABA
transporters in the cell membrane is highly dynamic and can be
modified in an activity-dependent manner. For example, there
are intracellular signaling cascades that regulate the cytoplasm-
to-surface partitioning of GABA transporters (Corey et al., 1994;
Whitworth and Quick, 2001) and the interaction between GABA
transporters and components of the cytoskeleton, which con-
trol the mobility of these molecules within the cell membrane
(Imoukhuede et al., 2009). In this review, we provide an overview
of the structural and functional properties of GABA transporters
and of the molecular mechanisms that can alter their expression
and mobility in the cell membrane.
THE GABA TRANSPORTER FAMILY AND THE GABA
TRANSPORTER GROUP
GABA transporters belong to a family of neurotransmit-
ter:sodium symporters that in humans is referred to as the solute
carrier 6 (SLC6) family. The SLC6 family is composed of 20 mem-
bers and, based on sequence composition, it is subdivided into
four groups including GABA, osmolyte and creatine transporters
(Figure 1, blue section), neurotransmitter amino acid (Figure 1,
pink section), monoamine (Figure 1, green section) and nutri-
ent amino acid/orphan transporters (Figure 1, gray section). The
currently accepted nomenclature that is used to identify mem-
bers of the SLC6 family represents the nomenclature of GABA
transporters in humans (A1-20) and rats (GAT, BGT, NTT, etc.).
The nomenclature of GABA transporters in mice is different
and somewhat confusing when compared to the ones mentioned
above. In mice, GAT2 corresponds to A12/BGT1, GAT3 corre-
sponds to A13/GAT2 and GAT4 corresponds to A11/GAT3, while
GAT1 carries the same name as in humans and rats (A1) (Nelson,
1998; Cohen-Kfir et al., 2005). In this review, for simplicity, we
use the human/rat GABA transporter nomenclature. There is
overlapping substrate specificity across all four groups of trans-
porters within the SLC6 family. For example, betaine is trans-
ported by A12/BGT1 and A20/SIT1, and A9/GlyT1, A5/GlyT2,
A19/B0AT1, A18/B0AT3, A14/ATB0, + all transport glycine across
the cell membrane (Broer and Gether, 2012). There is also over-
lapping substrate specificity within each group of the SLC6 family.
For example, the monoamine transporters have low selectiv-
ity for decarboxylated derivatives of aromatic aminoacids like
tyrosine and triptophane. Accordingly, the dopamine transporter
A3/DAT also transports noradrenaline (Broer and Gether, 2012),
the noradrenaline transporter A2/NET also transports dopamine
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FIGURE 1 | Molecular phylogenetic analysis of the SLC6
neurotransmitter transporter family in Homo sapiens. The SLC6 family
is divided into four groups, including the GABA (blue), aminoacid (pink),
monoamine (green) and aminoacid/orphan transporters (gray). The
evolutionary history is inferred by using the maximum likelihood method
based on the JTT matrix-based model (Jones et al., 1992). The initial tree
for the heuristic search is obtained automatically by applying neighbor-join
and BioNJ algorithms to a matrix of pairwise distances estimated using a
JTT model, and then selecting the topology with superior log likelihood
value. The analysis is performed on 19 aminoacid sequences because the
gene encoding the SLC6A10 transporter is thought to be a pseudogene
(Kristensen et al., 2011). All positions containing gaps and missing data
were eliminated. There is a total of 372 positions in the final dataset. The
evolutionary analysis is obtained with MEGA5 (Tamura et al., 2011). The
tree is not drawn to scale; it includes the SLC and the commonly used
neurotransmitter transporter nomenclature. The stoichiometry and direction
of the transport cycle are included, when known, together with the
corresponding reference.
(Gether et al., 2006) and the serotonin transporter A4/SERT also
transports dopamine, albeit with low-affinity (Larsen et al., 2011).
The GABA transporters group comprises six transporters:
A1/GAT1, A13/GAT2, A11/GAT3, A12/BGT1, A8/CT1, and
A6/TauT. All members can transport GABA and other molecules
and there is overlapping substrate specificity also within the
GABA transporters group. For example, GAT2 and GAT3 accept
substrates with a carboxyl group in the β-position and an
amino group in the γ-position of their carbon backbone struc-
ture, like GABA and β-alanine. Conversely, taurine, which has
a sulphonate—not a carboxyl—group in the β-position, is only
transported by TauT; creatine, in which the amino group in the
γ-position is part of the guanidino group, is only transported by
CT1; betaine, in which this group is methylated, is only trans-
ported by BGT1. GAT1, GAT2, and GAT3 (particularly GAT1) are
the most extensively characterized GABA transporters and will be
the main focus of discussion in this review.
THE BIOPHYSICAL PROPERTIES
The early experiments involving solubilization of GABA trans-
porters from rat brains and subsequent reconstitution in pro-
teoliposomes revealed four important biophysical properties of
GABA transporters (Kanner, 1978). First, they showed that GABA
transport is an active process, not directly coupled to ATP hydrol-
ysis but requiring the presence of an inward electrochemical
gradient for Na+, typically created by the membrane Na+/K+
ATPase. Second,GABA transporters have lowmicromolar, steady-
state affinity for GABA, with a Michaelis-Menten constant of
2.5μM [later found to be 3.1–10.6μM for GAT1 (Guastella et al.,
1990)]. Third, replacement experiments in which Li+, NH4+,
Tris+, K+ were used as substitutes for Na+ showed that GABA
transport is only supported by Na+, not by any of the other
cations (see also Iversen and Neal, 1968). Fourth, the increase
in GABA uptake observed in the presence of the K+-selective
ionophore valinomycin indicated that GABA transport is elec-
trogenic (and voltage-dependent) (Kanner, 1978). These funda-
mental aspects of GABA transporter function were all confirmed
when GABA transporters were purified (Radian and Kanner,
1985) and identified (Radian et al., 1986) and when the first
member of the GABA transporter subgroup, GAT1, was cloned
(Guastella et al., 1990). Kinetic and thermodynamic experiments
indicate that, in addition to Na+, extracellular Cl− is also required
for GABA transport. These findings are thought to be consis-
tent with the existence of a co-transport mechanism for GABA,
Na+ and Cl− by GABA transporters. Accordingly, the most
accredited stoichiometry of mammalian GABA transporters is
1GABA:2Na+:1Cl−. Since GABA is a zwitterionic molecule, this
stoichiometry leads to a net influx of one positive charge per
transport cycle (Radian and Kanner, 1983; Kavanaugh et al.,
1992; Mager et al., 1993; Lu and Hilgemann, 1999b). In some
radioactive tracer flux experiments, however, a net charge influx
of two positive charges per transport cycle has been measured
(Pastuszko et al., 1982; Loo et al., 2000). Because activation of
GABA transporters triggered simultaneous influx and efflux of
Cl− (Loo et al., 2000), it was proposed that there is an exchange
mechanism that couples Cl− influx and efflux across the cell
membrane. If this were the case, the proposed stoichiometry
of 1GABA:2Na+:1Cl− would only reflect the stoichiometry of
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GABA influx, but the net stoichiometry for the entire trans-
port cycle would be 1GABA:2Na+. It has been reasoned that
co-transporting Cl− together with Na+ and GABA would add
very little energy to drive the uphill transport of GABA, because
the reversal potential for Cl− is close to the resting membrane
potential (Loo et al., 2000). This reasoning obviously holds only if
considering GABA transport in cellular or sub-cellular compart-
ments where the reversal potential for Cl− is hyperpolarized, at
a time when the cell is not experiencing any depolarizing event
(e.g., action potential firing, sub-threshold depolarization). The
counter argument, however, is that the functional relevance of
an electroneutral exchange of Cl− across the cell membrane is
unclear. Recent kinetics experiments indicate that Cl− is only
required for the generation of GABA-induced steady-state cur-
rents, not for GABA-induced pre-steady-state currents, which
reflect the first electrogenic steps in the transport cycle (Bicho
and Grewer, 2005). This result could be explained if Cl− exchange
occurred in a reaction step distinct from—but thermodynam-
ically coupled to—the translocation of GABA and Na+ across
the membrane. The Cl− exchange would occur while the trans-
porter is in a conformational state that allows it to take up GABA
and Na+ (Bicho and Grewer, 2005). Cl− binding to the extra-
cellular side of GAT1 could facilitate intracellular GABA release
from the transporter. Therefore the entire forward transport cycle
would include rapid binding and translocation of GABA and
Na+, slower (12ms) intracellular dissociation of GABA and Na+
and rapid Cl− exchange (Bicho and Grewer, 2005).
THE TURNOVER RATE OF GABA TRANSPORTERS
There are numerous and different estimates for the transloca-
tion rate of GABA and co-transported ions across the membrane
via GAT1. For the forward mode (i.e., the mode that describes
removal of GABA from the extracellular space toward the cyto-
plasm and transporter re-orientation in the cell membrane),
the initial estimates at 22◦C suggested a value of 2.5 s−1 in
Xenopus oocytes (Radian et al., 1986). This value agrees well
with the turnover rate found by others in the same preparation
and in similar experimental conditions: 5.8–7.6 s−1 at −60mV
(Eckstein-Ludwig et al., 1999), 6.3 s−1 at −60mV (Liu et al.,
1998), 6–13 s−1 at−80mV (Mager et al., 1993), 13 s−1 at−40mV
(Bicho and Grewer, 2005). However, other reports have also esti-
mated turnover rates at 37◦C and−50–90mV of 73–93 s−1, much
higher than it would be predicted by correcting the previous val-
ues for the estimatedQ10 value of 2.8 (Gonzales et al., 2007). This
discrepancy may be attributed to methodological differences, as
the latter estimates are obtained using correlative freeze-fracture
and electrophysiology experiments. For the reverse mode (i.e., the
mode that describes GABA release into the extracellular space and
transporter re-orientation in the cell membrane), the available
estimates suggest turnover rates of 3 s−1 at −120mV and 60 s−1
at +120mV at 33◦C (Lu and Hilgemann, 1999a).
THE CURRENTS ASSOCIATED WITH GABA TRANSPORT
The initial biophysical characterization of GAT1 expressed het-
erologously in Xenopus oocytes did not provide an indication
that GAT1 could generate any other current than the stoichio-
metric current described above (Hilgemann and Lu, 1999; Lu and
Hilgemann, 1999a,b). Once GAT1 was expressed in HEK293 and
HeLa cells, however, it became evident that GABA binding to
GAT1 gates at least two more currents that are stoichiometrically
uncoupled from the translocation of GABA, Na+ and Cl− across
the membrane. The two stoichiometrically uncoupled currents
are: (1) an agonist-induced Na+ inward current (Risso et al.,
1996); (2) an agonist-independent leak cationic current carried
by alkali ions (Cammack and Schwartz, 1996). The lack of these
currents in Xenopus oocytes may reflect different functional prop-
erties of GAT1 in Xenopus vs. mammalian expression systems (Lu
and Hilgemann, 1999b). They may also be due to a technical lim-
itation of Xenopus oocytes, where small Na+ currents are not
easily resolved (Lu and Hilgemann, 1999b). Even though a fully
detailed, direct comparison between the agonist-induced stoi-
chiometrically coupled and uncoupled currents in these different
expression systems is not available, the Na+-inward current could
actually be significantly larger than one would expect based on the
Xenopus oocytes studies. In fact, it has been suggested that this
current could contribute 4-10 times more current than the sto-
ichiometric component of GAT1 (Eckstein-Ludwig et al., 1999).
Competitive GAT1 antagonists like tiagabine block both the sto-
ichiometric and the Na+ inward current with Ki values of 2 and
0.3μM, respectively (Eckstein-Ludwig et al., 1999). In contrast,
the GAT1 inhibitor SKF899A can be used to separate these two
current components, because SKF89976A acts as a low-affinity,
competitive antagonist of the stoichiometric current (Ki = 7μM)
and as a high-affinity, non-competitive antagonist for the Na+
inward current [Ki = 0.03μM (Krause and Schwarz, 2005)]. The
contribution of the leak current to the total current generated by
GAT1 ismodest. This is in part due to the fact that its conductance
is small [gleak = 0.36 ± 0.18 nS (Cammack and Schwartz, 1996)]
and in part to the fact that this current is inhibited by intracel-
lular Na+ concentrations that are typically found in the cytosol
of living cells (Ki = 3mM) and often reproduced during elec-
trophysiological patch-clamp recordings (Macaulay et al., 2002).
The ability of GAT1 to act as a channel as well as a transporter
is not an uncommon feature among neurotransmitter trans-
porters: it is reminiscent of themechanisms of action of glutamate
transporters, which also generate agonist-induced stoichiomet-
rically coupled and uncoupled currents (Wadiche et al., 1995).
For both GABA and glutamate transporters, the stoichiometric
current is inwardly directed. However, the agonist-induced stoi-
chiometrically uncoupled current is cationic (and depolarizing)
in GABA transporters and anionic (and often hyperpolarizing)
in glutamate transporters. Activation of the stoichiometrically
uncoupled, glutamate transporter anionic current in retinal rod
bipolar cell terminals hyperpolarizes the cell membrane and
inhibits neurotransmitter release (Veruki et al., 2006). The role
of the stoichiometrically uncoupled, GABA transporter cationic
current is not known but one hypothesis is that activation of this
current at pre-synaptic inhibitory terminals could serve as a nega-
tive feedback mechanism that, by depolarizing the cell membrane
potential, ultimately inhibits GABA uptake.
One other functional aspect of the agonist-induced stoichio-
metrically coupled and uncoupled currents that remains cur-
rently unknown is whether they share a common permeation
pathway with the substrate or if, as proposed for analogous
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currents generated by agonist binding to glutamate transporters,
the two pathways are independent from one another (Ryan et al.,
2004). Although this and other mechanistic questions about
GABA transporters remain currently unanswered, the recent dis-
covery of the crystal structure of LeuTAa, a bacterial homolog
from Aquifex aeolicus (Yamashita et al., 2005) could allow for an
unprecedented detailed level of understanding of this and other
details about the transport process.
THE STRUCTURE OF A PROKARYOTIC GABA TRANSPORTER
HOMOLOG
Aquifex aeolicus is a thermophilic bacterium that grows best at
95◦C. The name refers to the fact that this bacterium produces
water as a byproduct of its respiration (hence Aquifex) and was
first isolated near underwater volcanic vents in the Aeolic Islands,
north of Sicily (hence aeolicus). LeuTAa is an experimentally
tractable prokaryotic leucine transporter. It is evolutionary dis-
tant from GAT1 and shares 20–25% sequence similarity with
GAT1 and other members of the SLC6 family including glycine,
dopamine and serotonin transporters (Yamashita et al., 2005).
The proposed stoichiometry of LeuTAa (1 leucine:2 Na+) indi-
cates that substrate transport via LeuTAa is not Cl−-dependent,
in contrast to GAT1. Despite these differences, the structural
conservation between LeuTAa and other members of the SLC6
family is thought to be remarkably high (Abramson and Wright,
2009). This supports the usefulness and validity of LeuTAa as
a template model for the analysis of the structural architec-
ture and function of transporters in the SLC6 family (Kristensen
et al., 2011). LeuTAa has a 70Å tall and 48Å wide cylindrical
structure with 12 transmembrane domains (TM1-12), intracel-
lular N- and C-terminal domains and extracellular, glycosylated
regions (Figure 2), as previously deduced from the hydropathy
analysis of the aminoacidic sequence of GAT1 (Guastella et al.,
1990). LeuTAa assembles as a dimer, with each protomer capa-
ble of independently binding and translocating leucine and the
two co-transported Na+ ions. According to FRET experiments,
GAT1 also assembles as a multimeric structure (Schmid et al.,
2001; Moss et al., 2009). Each monomer is capable of trans-
porting GABA independently (Soragna et al., 2005), but the
multimerization process allows trafficking of GAT1 from the
endoplasmic reticulum to the plasma membrane (Farhan et al.,
2006). The essential core structure of LeuTAa is formed by TM1-
10. TM11-12 participate in multimerization and the N- and
C-terminal domains are not required for GABA transporter activ-
ity (Mabjeesh and Kanner, 1992). Consistent with these findings,
other functional bacterial homologs of GAT1, like the trans-
porter protein encoded by the tnaT gene of Symbiobacterium
thermophilum, consist only of TM1-10 (Androutsellis-Theotokis
et al., 2003). Some of the key residues in TM1-10 include: (1) Arg
69 (TM1), essential for substrate transport (Pantanowitz et al.,
1993); (2) Gly80 (TM2), necessary for conformational transi-
tions during the transport process (Zhou and Kanner, 2005);
(3) Tyr140 (TM3), involved in substrate recognition and trans-
port (Bismuth et al., 1997). One of the major novel findings
recently emerged from the crystal structure of LeuTAa is that
there is an internal structural repeat that allows an ideal super-
imposition of TM1-5 with TM6-10 by a 176.5◦ rotation around
a pseudo-two-fold axis located in the plane of the membrane
(Yamashita et al., 2005). TM1 and TM6 are oriented antiparal-
lel to each another, with breaks in their helical structure half-way
through the cell membrane. In the substrate-bound, outward-
occluded and competitive inhibitor-bound outward-facing con-
formation, Val23 and Gly24 in TM1 and the aminoacidic residues
between Ser256 and Gly260 in TM6 have extended non-helical
conformations, which expose atoms that can be used for hydro-
gen bonding and ion coordination. The regions surrounding
these unwound breaks in TM1 and TM6, together with other
regions in TM3 and TM8, comprise the substrate and Na+-
binding sites (Yamashita et al., 2005). Hinge movements allow
TM1b, TM2a, TM6a to pivot around Val23, Gly55, and Leu257
and move outwards, in the Na+-bound, substrate-unbound out-
ward open conformation. These movements cause the extracel-
lular loop 3 (EL3) and TM11 to be displaced by 2.8Å and 2.2Å,
respectively (Krishnamurthy and Gouaux, 2012). In the inward-
open conformation, TM1b and TM6a move and block the extra-
cellular pathway, while TM1a is tilted by 45◦ with respect to its
position in the closed state (Krishnamurthy and Gouaux, 2012).
TM2, TM5, and TM7, domains that buttress TM1 and TM6,
bend and cause EL4 to move down into the extracellular vestibule
and close the extracellular solvent pathway. These structural rear-
rangements of LeuTAa are consistent with an alternating access
transport mechanism, whereby conformational changes in the
structure of a transporter switch the accessibility of the substrate-
binding site from the extracellular and cytoplasmic side of the
membrane (Jardetzky, 1966; Lauger et al., 1980). The probabil-
ity of a transporter of being in one state vs. the other depends on
the energetic barriers associated with each conformational tran-
sition, which in turn depend on the substrate and co-transported
ion concentration and on the membrane potential (Chung and
Eaton, 2013; Schuler and Clarke, 2013).
THE DISTRIBUTION OF GABA TRANSPORTERS IN THE
BRAIN
In situ hybridization studies have shown that the mRNA encod-
ing GABA transporters is widely distributed throughout the entire
central nervous system (Durkin et al., 1995; Borden, 1996).
Intense labeling for the GABA transporter GAT1 is found in
the cerebellum (molecular layer), basal ganglia (ventral pallidum,
globus pallidus), olfactory bulb (glomerular layer), retina (inner
nuclear layer), and interpeduncular nucleus. Moderate label-
ing is found throughout the neocortex (hippocampus proper
and dentate gyrus), amygdala, septum, thalamus (ventral lateral
geniculate, reticular nuclei), zona incerta, subthalamic nucleus,
hypothalamus (suprachiasmatic and periventricular nuclei, ante-
rior hypothalamic and pre-optic areas), superior colliculus, dorsal
tegmental nuclei, basal ganglia (substantia nigra), nucleus of
Darkschewitsch, pons and medulla (trapezoid, medial and lat-
eral vestibular, dorsal cochlear and parabrachial nuclei, nucleus
of the solitary tract and of the trigeminal nerve) and also in
the spinal cord (dorsal horn laminae 1, 2, 4, 10). Weak labeling
is found in cerebellar Purkinje cells, deep cerebellar nuclei and
also in the spinal cord (ventral horn). In contrast to GAT1, the
mRNA encoding the GABA transporter GAT2 is only detected
in the leptomeninges, possibly suggesting a role for GAT2 in
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FIGURE 2 | Secondary structure and surface representation of LeuTAa.
(A) Topology of Aquifex aeolicus LeuTAa. The transporter is composed of 12
trans-membrane regions (TM1-12), with cytoplasmic N- and C-terminal
domains. TM1 and TM6 are oriented antiparallel to one another and have
breaks in their helical structure approximately halfway across the membrane
bilayer. The transporter has two extracellular β-strands (green arrows), four
extracellular (EL2, 3, 4a, 4b) and two intracellular helices (IL1, 2). The
co-transported Na+ are depicted as two light green spheres. The substrate
molecule (Leu), is depicted as a bigger blue sphere that binds to unwound
regions in TM1 and TM6. Modified from (Yamashita et al., 2005). (B) Slice
through the surface representation of LeuTAa in the Leu-free, Na+-bound
outward-open conformation (left), in the occluded conformation where the
Leu- and Na+-binding sites are occluded from solution in the extracellular and
cytoplasmic sides (middle) and in the inward-open conformation (right). The
zig-zag pink lines indicate closed intracellular pathways. Modified from
(Yamashita et al., 2005) and (Krishnamurthy and Gouaux, 2012).
regulating the GABA concentration or the osmotic pressure in
the cerebrospinal fluid. The mRNA encoding the GABA trans-
porter GAT3 is less abundantly expressed than the one for
GAT1. Intense labeling is found in the olfactory bulb (glomeru-
lar layer) and retina (inner nuclear layer). Moderate labeling is
found in the septum (medial nucleus and vertical nucleus of
the diagonal band), basal ganglia (ventral pallidum and globus
pallidus), subfornical organ, amydala, thalamus (paraventricular
nucleus, lateral habenula), superior colliculus, ventral tegmen-
tal nucleus, basal ganglia (substantia nigra pars compacta), and
medial vestibular nucleus. Weak labeling is found in lateral retic-
ular and parabrachial nuclei, deep cerebellar nuclei, spinal cord
and in the entire neocortex (Borden, 1996). The immunohisto-
chemical analysis largely confirms these results, particularly the
faint expression of GAT2 throughout the central nervous sys-
tem, as opposed to other peripheral organs (Ikegaki et al., 1994),
and the widespread distribution of GAT1 and GAT3 throughout
the brain (Ikegaki et al., 1994). The highest levels of expression
of GAT1 are found in the hippocampus, olfactory bulb, cortical
layer 1 (L1), piriform cortex, superior colliculus, interpeduncu-
lar nucleus and nucleus spinal tract of the trigeminal nerve. The
highest levels of expression of GAT3 are found in the olfactory
bulb, thalamus, hypothalamus, pons and medulla, globus pal-
lidus, basal ganglia (substantia nigra), deep cerebellar nuclei,
and nucleus spinal tract of the trigeminal nerve (Ikegaki et al.,
1994). The density of expression of GAT1-3 in the cortex varies
across layers (Figure 3). GAT1 immunostaining is highest in L2-
L4, GAT2 is confined to the meninges and GAT3 is most highly
expressed in L3 and upper L5 (Minelli et al., 1996; Conti et al.,
2004).
THE CELLULAR AND SUB-CELLULAR DISTRIBUTION OF
GABA TRANSPORTERS
One of the most interesting features of GAT1 and GAT3 is their
cellular and sub-cellular distribution.
In rodents, the punctate immunostaining for GAT3 is local-
ized exclusively in astrocytic processes scattered throughout the
neuropil and adjacent to symmetric and asymmetric synapses
close to cell bodies, basal and apical dendrites (Minelli et al.,
1996; Ribak et al., 1996; Melone et al., 2005 but see Pow et al.,
2005). In the brain of other mammalian species, like cats, mon-
keys and humans, the astrocyte-specific expression of GAT3 is
lost, because here GAT3 is also expressed in oligodendrocytes
(Pow et al., 2005).
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FIGURE 3 | Distribution of GABA transporters in the rat somato-sensory
cortex. (A) Immunohistochemical labeling for the GABA transporters GAT1
(left), GAT2 (middle) and GAT3 (right) in the primary somato-sensory cortex of
the adult rat. Modified from (Conti et al., 2004). (B) Image analysis of the
immunohistochemical labeling for GAT1-3. The diagrams provide a measure
of the normalized, average gray value distribution measured over the entire
area of the images shown in panel A. The data are normalized by the
maximum gray value measured in each image. Therefore, the darkest areas,
with the most intense labeling, have a normalized gray intensity value of 1.
The letters on the right hand side of the figure indicate the meningeal (M)
and the six cortical layers (L1–6). The gray value analysis was done using the
Fiji image processing package (Schindelin et al., 2012). The rest of the
analysis was performed using custom-made routines written in Igor Pro
(Wavemetrics).
At the electron microscope level, the punctate GAT1
immunoreactivity is mainly confined to the axon terminals of
symmetrical synapses in the neocortex (Figure 4A). For the most
part, this labeling overlaps with that of GAD67-positive termi-
nals located near neuronal cell bodies, axon initial segments and
proximal dendrites (Minelli et al., 1995; Ribak et al., 1996), but
some GAT1 immunoreactivity has also been detected in distal
astrocytic processes (Minelli et al., 1995; Ribak et al., 1996) and
post-synaptically, in the dendrites and soma of non GABAergic
neurons (Yan et al., 1997). The pre-synaptic neuronal location of
GAT1 seems suited for GABA recycling in the pre-synaptic termi-
nal following a release event. This suggests that GABA uptake, not
only GABA biosynthesis, is essential to sustain GABAergic synap-
tic transmission. The function of post-synaptic GAT1 in incom-
pletely understood, but if we could draw an analogy with what
we have learnt from the activity of neuronal post-synaptic trans-
porters at excitatory synapses (Scimemi et al., 2009), we would
probably infer that they may limit GABA escape from the synaptic
cleft toward extra-synaptic territories. The density of expres-
sion of GAT1 in cortical and cerebellar plasma membranes has
been estimated with fluorescent labeling experiments (Chiu et al.,
2002). According to these findings, GAT1 is expressed at a density
of 500–800μm−2, 61–63% of the total density of expression of
GAT1 in intracellular and plasma membranes (800–1300μm−2).
These tentative estimates are useful to develop quantitative frame-
works to determine the function of GABA transporters in the
synapse (Scimemi, 2014). Because they represent average density
values, however, they imply that synapses with a large surface
area express a higher number of GABA transporters than small
synapses. There is no clear experimental evidence that supports
this assumption. Another important piece of information that
is currently missing is whether the relative abundance of GAT1
vs. GAT3, and their relative contribution to synaptic function,
varies across synapses with different levels of astrocytic coverage.
Therefore, one of the current major limitations is that our under-
standing of GABA transporters is based on “average” quantitative
estimates that do not capture the effect of cell-to-cell variabil-
ity in GABA transporter expression/activity on synaptic function.
There are in fact indications that the expression level of GAT1
vary significantly across GABAergic interneurons. For example,
in the hippocampus, GAT1 is more abundantly expressed in stra-
tum radiatum rather than stratum oriens interneurons (Engel
et al., 1998). Accordingly, the amplitude and time course of
GABAergic IPSCs evoked in CA1 pyramidal cells by stimulat-
ing stratum radiatum interneurons show higher sensitivity to
the GAT1 inhibitor tiagabine than those evoked by stimulating
stratum oriens interneurons (Engel et al., 1998). There are exam-
ples of GABAergic cells, like cerebellar Purkinje neurons, that
lack GAT1 and any designated mechanism for GABA uptake in
the pre-synaptic terminal (Minelli et al., 1995). Here the GABA
transporter responsible for GABA clearance from the extracellu-
lar space is GAT3, which is highly expressed in Bergmann glial
cell processes surrounding the synaptic terminal (Figure 4B).
Something similar occurs in the thalamus, where GABA trans-
porters are only expressed in astrocytes (De Biasi et al., 1998;
Vitellaro-Zuccarello et al., 2003). Interestingly, in the thalamus,
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FIGURE 4 | The cellular and sub-cellular distribution of GABA
transporters. (A) Schematized morphology of cortical pyramidal neuron
(top) and of the distribution of GAT1 (green) and GAT3 (blue) at synaptic
contacts onto these cells (bottom). (B,C) As in A, for Purkinje (B) and
thalamic relay neurons (C). At GABAergic synapses onto cortical neurons,
GAT1 and GAT3 are expressed mainly in pre-synaptic terminals and in
neighboring astrocytic processes, respectively. Purkinje neurons lack
neuronal GABA transporters; Bergmann glia cells express GAT3. GABA
uptake at synaptic contacts onto thalamic relay neurons is mediated by
GAT1 and GAT3. Both transporters are located in astrocytes: GAT1 is
located closer to the synapse and clears GABA released during phasic
events; GAT3 is located further away and regulates the basal, tonic
GABA concentration in the extracellular space (Beenhakker and
Huguenard, 2010).
GAT1 and GAT3 may occupy distinct domains within the astro-
cytic membrane, with GAT1 located closer to synaptic contacts
than GAT3 (Beenhakker and Huguenard, 2010) (Figure 4C). This
peculiar distribution may allow GAT1 and GAT3 to have different
roles on synaptic function: the former limiting GABA escape from
the synaptic cleft during phasic synaptic transmission, the lat-
ter controlling the ambient GABA concentration mediating tonic
inhibition (Beenhakker andHuguenard, 2010). These findings are
consistent with the recently emerging view that GAT1 and GAT3
regulate different signaling pathways, mediated by GABA released
via vesicular and non-vesicular mechanisms (Song et al., 2013),
during low-frequency or sustained neuronal activity (Kersante
et al., 2013).
THE FUNCTIONAL ROLE OF GABA TRANSPORTERS
GABA transporters can transiently bind extracellular GABA,
remove it from the extracellular space and, under appropriate
ionic conditions, translocate it from the cytosplasm back into
the extracellular space (Figure 5A). The diversity of these effects
indicates that the functional implications of GABA uptake on
synaptic transmission are multiple and complex. There have
been apparently conflicting results on the ability of GABA trans-
porters to control the time course of GABAergic currents. This is
because inhibiting GABA uptake markedly prolongs the neuronal
response to iontophoretic GABA applications (Curtis et al., 1976;
Brown and Galvan, 1977; Brown et al., 1980; Alger and Nicoll,
1982; Dingledine and Korn, 1985) and to repetitive synaptic
stimulations (Roepstorff and Lambert, 1992; Thompson and
Gahwiler, 1992; Isaacson et al., 1993; Draguhn and Heinemann,
1996; Overstreet and Westbrook, 2003) (Figure 5B). It also pro-
longs the late phase of evoked inhibitory post-synaptic currents
[IPSCs; (Dingledine and Korn, 1985; Isaacson et al., 1993)] but
has little effect on the amplitude and initial decay of action poten-
tial independent miniature and unitary IPSCs (Dingledine and
Korn, 1985; Rekling et al., 1990; Thompson and Gahwiler, 1992;
Isaacson et al., 1993; Rossi and Hamann, 1998; Overstreet and
Westbrook, 2003) (Figure 5B). The discrepancy between these
results has been partly resolved over the years based on theo-
retical and experimental works showing that: (1) the ability of
GABA transporters to alter receptor activation depends on the
amplitude and time course of the GABA concentration tran-
sient; (2) GABA diffusion and GABA receptor kinetics—not
GABA uptake—shape the profile of synaptic currents evoked by
brief agonist concentrations; (3) GABA uptake regulates GABA
receptor activation during simultaneous recruitment of neigh-
boring synapses; (4) GABA uptake limits GABA escape from
active synapses (i.e., spillover) and therefore controls the spa-
tial specificity of GABAergic transmission (Dingledine and Korn,
1985; Isaacson et al., 1993; Overstreet et al., 2000, 2003). When
GABA uptake is intact, there is a progressive decline in the
proportion of time that GABAA receptors spend in the open
vs. desensitized state at increasing distances from active release
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FIGURE 5 | The mode of action and functional effect of GABA
transporters on synaptic transmission. (A) Schematic representation of
the three different modes of action of GABA transporters. GABA
molecules (transparent spheres) can be rapidly bound by GABA
transporters. Not all the GABA molecules that are bound by the
transporters are also translocated across the cell membrane. Under these
conditions, the transporters act as buffers (left). GABA uptake is coupled to
the movement of Na+ (orange sphere) and Cl− (green sphere) across the
membrane. In forward mode, GABA transporters remove GABA from the
extracellular space (middle). GABA transporters can operate in revered
mode (i.e. release GABA in the extracellular space) if the driving force for
Na+/Cl− favors the movement of these ions outside the cell, and if the
intracellular concentration of GABA is sufficiently high to be bound by the
transporters (right). (B) Schematic representation of the effects of GABA
uptake on small, fast, coincident and tonic GABAergic currents. The black
traces represent currents recorded in control conditions, with GABA
uptake intact. The blue traces represent currents recorded when GABA
transporters are blocked.
sites (Overstreet et al., 2003). This decline becomes more gradual
when GABA transporters are blocked, because a larger fraction
of GABAA receptors away from the release site open, rather than
desensitize, following GABA release (Overstreet et al., 2003).
Taken together, these findings indicate that a key role of GABA
transporters in cortical microcircuits is to convert a spatially con-
fined signal into a spatially unrestricted wave of inhibition capable
of activating a broad range of pre- and post-synaptic GABAA
and GABAB receptors. The likelihood with which these broad
range effects occur varies across synapses, depending on the ago-
nist concentration profile and the diffusion properties of the
synaptic and peri-synaptic environments. In the hippocampus,
GABA release from parvalbumin-expressing (PV) interneurons
evokes post-synaptic currents that last <1ms. In contrast, the
currents evoked by GABA release from neurogliaform cells last
>100ms (Hajos et al., 2000; Tamas et al., 2003; Olah et al.,
2009; Barberis et al., 2011; Capogna and Pearce, 2011; Chittajallu
et al., 2013). Slow GABAergic currents are more susceptible to the
activity of GABA transporters, suggesting that slow waves of inhi-
bition, rather than rapid point-to-point communication ismainly
modulated by GABA transporters (Szabadics et al., 2007). In hip-
pocampal CA1 pyramidal cells, blocking GABA uptake causes
a more pronounced increase in somatic than dendritic currents
evoked by exogenous GABA applications (Isaacson et al., 1993).
This effect has been attributed to the existence a larger proportion
of somatic, rather than dendritic, GABAergic inputs onto these
cells. As a consequence, the local concentration of GAT1 (the
most abundant GABA transporter in this brain region) is higher
at the soma than along the dendrites of CA1 pyramidal cells
(Gulyas and Freund, 1996; Miles et al., 1996). Interestingly, many
peri-somatic GABAergic inputs onto CA1 pyramidal cells come
from PV interneurons (Freund and Buzsaki, 1996; Klausberger
and Somogyi, 2008). It is therefore puzzling that there is a high
concentration of GAT1 in a sub-cellular compartment where
individual GABAergic IPSCs have rapid kinetics and are largely
unaffected by blocking GABA uptake. One possible explanation
is that peri-somatic GAT1 serves to limit GABA diffusion away
from the somatic region during repetitive activation of PV cells
and toward the somatic region following the onset of slow waves
of dendritic inhibition. If confirmed, this hypothesis may suggest
that the main functional role of peri-somatic GABA transporters
is to maintain a spatial separation between somatic and dendritic
GABAergic signals.
An additional form of GABAergic signaling is the one medi-
ated by tonic activation of GABA receptors (Brickley et al., 1996).
These currents are due to the continuous presence of a low sub-
micromolar concentration of GABA in the extracellular space
(Scimemi et al., 2005; Santhakumar et al., 2006; Wu et al., 2007).
That is to say that GABA transporters, despite being able to
remove GABA from the extracellular space, do not lower its
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concentration to levels that prevent it from activating GABA
receptors. Tonic GABA currents have been recorded in a vari-
ety of cells in vitro (Brickley et al., 1996; Rossi and Hamann,
1998; Hamann et al., 2002; Nusser and Mody, 2002; Mitchell and
Silver, 2003; Semyanov et al., 2003; Stell et al., 2003; Caraiscos
et al., 2004; Scimemi et al., 2005; Wojtowicz et al., 2013) and
in vivo (Chadderton et al., 2004; Duguid et al., 2012; Kersante
et al., 2013; Rovo et al., 2014) (Figure 5B). The functional role
of tonic GABA currents is to reduce the neuronal input con-
ductance (Cavelier et al., 2005; Farrant and Nusser, 2005), but
the consequences that this has on cell excitability depend on
the temporal profile of incoming excitatory inputs (Mitchell and
Silver, 2003). The tonic GABA current offsets the cell’s output
firing rate in response to sustained depolarization and alters the
slope of the cell’s input-output relationship in response to a ran-
dom train of excitatory inputs (Mitchell and Silver, 2003). In the
cerebellum, it enhances the sensitivity of granule cells to evoked
vs. spontaneous sensory stimulation (Duguid et al., 2012) and
in the thalamus it controls the onset of neural network oscilla-
tions (Rovo et al., 2014). Therefore, by regulating tonic forms
of signaling, GABA transporters can exert a powerful control of
the accuracy with which information is relayed across cells and
brain regions. The electrochemical gradient for Na+/Cl− deter-
mines the direction of GABA transport, and therefore the ability
of GABA transporters to reduce or increase the extracellular
GABA concentration. Accordingly, previous reports indicate that
GABA transporters can operate in reverse mode (Wu et al., 2007).
They do so under experimental conditions that mimic ischemia
(Allen et al., 2004), but there is an ongoing debate on whether
reverse GABA uptake typically occurs under more physiological
conditions (Heja et al., 2012; Wojtowicz et al., 2013).
THE REGULATION OF GABA TRANSPORTER DENSITY OF
EXPRESSION
GABA transporters, like other neurotransmitter transporters,
are dynamically regulated at the level of their surface-to-
cytoplasm partitioning and anchoring to the cell membrane
(Figure 6). In Xenopus oocytes, activating protein kinase C (PKC)
with phorbol esters like phorbol-12-myristate-13-acetate (PMA)
and 1-oleoyl-2-acetyl-sn-glycerol (OAG), or with N-heptyl-5-
chloro-1-naphtalenesulphonamide (SC-10) and (-)-indolactam
V (indoV) enhances GABA uptake via GAT1, whereas inhibit-
ing PKC with bisindolyilmaleimide reduces it (Corey et al.,
1994). Consistent with these findings, inhibiting the phosphatase
PP2B (calcineurin) enhances GABA uptake (Corey et al., 1994).
Notably, the effects of PKC and PP2B onGABA uptake are entirely
post-translational because they can be detected even in the pres-
ence of cycloheximide, a protein synthesis inhibitor. PKC and
PP2B are thought to alter the trafficking of GAT1 from trans-
Golgi and/or low density cytoplasmic vesicles to the plasmamem-
brane by modulating the phosphorylation state of non-consensus
sites on GAT1 and/or the activity of second messenger signaling
cascades. These changes in the surface-to-cytoplasm expression
of GAT1 are associated with changes in the translocation rate
of GABA via GAT1 (Vmax), not in the Michaelis-Menten con-
stant for GABA uptake via GAT1 (Km), suggesting that they do
not alter GAT1 binding affinity for the substrate (Corey et al.,
1994). The magnitude of these effects depends on the abundance
of expression of GAT1 in the plasma membrane: the more GAT1
is present on the plasma membrane, the smaller is the mod-
ulatory effect of PKC. However, any attempt to generalize the
findings obtained in Xenopus oocytes to other cell types should
be pursued with caution. In rat brain cortical cultures, pharmaco-
logical activating PKCwith PMA, phospholipase C (PLC) or OAG
(the endogenous, membrane permeable analog of DAG gener-
ated from phosphatidylinositol breakdown by PLC) does not alter
GABA uptake in neurons but decreases it in glial cells (Gomeza
et al., 1991). In rat hippocampal cultures, PMA reduces GABA
uptake in neurons but not in glial cells (Beckman et al., 1998).
Enhancing PKC activity indirectly, with agonists of G-protein-
coupled neurotransmitter receptors that lead to PKC activation
also reduces GABA uptake in neurons (Beckman et al., 1999).
Accordingly, agonists of acetylcholine muscarinic receptors (M1,
M3 and M5), glutamate metabotropic receptors (group I) and
serotonin receptors (5-HT2) all reduce GABA transporter cell
membrane expression by activating PKC (Beckman et al., 1999).
Although puzzling and largely unresolved, the discrepancy in
the effect of PKC activation on GABA transporters in Xenopus
oocytes, cultured neurons and glial cells may be attributed to dif-
ferences in the concentration of PKC in all these different cell
types. This suggests that in vivo the influence of PKC on GAT1
activity may vary significantly depending on the amount and
specific PKC isoform expressed in different neurons and, pos-
sibly, in different sub-cellular compartments (Takai et al., 1977;
Nishizuka, 1988).
A distinct mechanism through which neurons can regulate
the cell-surface expression of GAT1 is via tyrosine kinase phos-
phorylation of intracellular tyrosine residues (Law et al., 2000)
(Figure 6A). These changes in the cell-to-cytoplasm partitioning
of GAT1 are due to reduced internalization of the transporter dur-
ing tyrosine kinase activation (Whitworth and Quick, 2001). In
rat hippocampal neurons, the effect of tyrosine kinases activation
is similar to that evoked by PKC inhibition, namely an increase
in GABA uptake due to enhanced cell membrane expression of
GAT1. Under physiological conditions, a possible candidate trig-
ger for tyrosine kinases activation is the growth factor BDNF,
which is synthesized and secreted by pyramidal neurons but
has target receptors in various types of GABAergic interneurons
(Ernfors et al., 1990). During development, GABA-inducedmem-
brane depolarization leads to opening of L-type voltage-gated
calcium channels and release of BDNF, which in turn promotes
interneuron differentiation (Marty et al., 1996a,b). By increas-
ing GABA uptake, BDNF may alter the concentration of GABA
in pre-synaptic terminals and its lifetime in the extracellular
space. As GABA becomes hyperpolarizing (Ben-Ari et al., 1989),
it loses its ability to activate L-type calcium channels and trigger
BDNF synthesis and release (Berninger et al., 1995). The conse-
quent reduction in GABA uptake may contribute to the reduced
neurotrophic effects of GABA in the mature brain.
THE REGULATION OF GABA TRANSPORTER LATERAL
MOBILITY
Previous works indicate that the localization of individual GAT1
molecules within the plasma membrane is not fixed in time and
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FIGURE 6 | Modulation of surface expression and lateral mobility of
GABA transporters. (A) Schematic representation of changes in cell
surface expression of GABA transporters evoked by altering the activity of
PKC and/or tyrosine kinase (TK). Both kinases regulate the trafficking of
GABA transporters from intracellular organelles (light, curved lipid bilayer)
to the cell membrane (dark, flat lipid bilayer). A reduction in the rate of cell
membrane insertion (bottom) leads to a decrease in the cell surface
expression of GABA transporters. (B) Schematic representation of the
molecular interactions mediating anchoring of GABA transporters to the
actin cytoskeleton. The MAGUK protein Pals1 mediates the interaction
between the C-terminal of GABA transporters and ezrin, an adaptor protein
that interacts with actin. Disruption of the interaction between Pals1 and
ezrin leads to an increased lateral mobility of GABA transporters in the cell
membrane.
is not entirely predicted by passive diffusion in the lipid bilayer
(Imoukhuede et al., 2009). This is in agreement with the results
of FRAP experiments in neuroblastoma 2a cells, in which 50% of
the total pool of GAT1 present in the cell membrane is mobile
while the remaining 50% is immobile. Within the immobile pop-
ulation, a fraction of GAT1 molecules is indirectly tethered to the
actin cytoskeleton via a PDZ-interaction between the C-terminal
domain of GAT1, the MAGUK protein Pals1 (Mchugh et al.,
2004) and ezrin, an adaptor protein that connects Pals1 to actin
(Imoukhuede et al., 2009) (Figure 6B). Disrupting the interaction
betweenGAT1 and the actin cytoskeleton (i.e., rendering all GAT1
molecules mobile) has been shown to increase GABA uptake
(Imoukhuede et al., 2009). However, these conclusions are based
on experimental measures of radioactive tracer flux typically
obtained under steady-state conditions (i.e., in the presence of an
unknown, but constant agonist concentration). There is hardly
anything that is at steady-state during synaptic transmission. For
example, the GABA concentration varies dramatically with time
and distance from the release site. It is therefore challenging to
get a simple and accurate intuition of whether and how changes
in the lateral mobility of GABA transporters can affect the GABA
concentration profile inside and outside the synaptic cleft. A sim-
ple modeling approach suggests that increasing the mobility of
GABA transporters along the cell membrane does not alter the
lifetime of GABA in the extracellular space but allows it to diffuse
further away from an active release site (Scimemi, 2014). This sug-
gests that intracellular signaling cascades that regulate the surface
expression and mobility of GABA transporters may ultimately
control the spatial specificity of GABAergic transmission in the
brain.
CONCLUSIONS
There have been tremendous advances in our understanding
of the molecular architecture and function of GABA trans-
porters. A number of works has shown that there are intracel-
lular signaling cascades that control the cell surface expression
and mobility of GABA transporters, suggesting that the regula-
tion of GABA transporter activity may be more complex than
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previously thought. It remains currently unclear how these short-
and long-term changes in the expression, mobility and activity
of GABA transporters affect the time course and spatial spread of
GABAergic signals in the brain. This missing piece of information
hold the promise of providing novel insights into the regulation
of synaptic transmission by GABA transporters and will shed new
light on our current understanding of the synaptic mechanisms
underlying the generation and maintenance of neuronal network
oscillations in distinct regions of the living brain.
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